A confluence of geopolitical developments and robust financial performance is providing significant tailwinds for Palantir Technologies. The data analytics firm finds itself at the intersection of rising defense technology demand and a strategic realignment within the U.S. Department of Defense’s artificial intelligence supply chain, all while posting record quarterly results.
Strategic Opening Amid Pentagon’s AI Supplier Review
A recent directive from Washington is emerging as a key market catalyst. U.S. defense agencies have been instructed to suspend commercial engagements with AI company Anthropic. Defense official Pete Hegseth has publicly reinforced that military contractors are also prohibited from conducting business with the firm.
This presents a dual scenario for Palantir. In the near term, it creates operational work as the company begins the process of removing Anthropic’s Claude software from its Maven Smart Systems. However, analysts see a longer-term strategic opportunity. The Pentagon’s increased focus on “politically secure” AI supply chains could reshuffle the competitive landscape for current and future defense programs, potentially opening doors for established government contractors like Palantir.
Financial Performance Exceeds Expectations
Beyond geopolitical factors, the company’s fundamental operational strength is a primary driver. Fourth-quarter revenue surged 70% year-over-year to approximately $1.41 billion. Non-GAAP earnings per share rose 79% to $0.25, surpassing the average Wall Street forecast of $0.23 on expected revenue of $1.33 billion.
A standout performer was the U.S. commercial segment, where quarterly revenue exploded by 137%. U.S. government revenue also saw substantial growth, increasing by 66%. The company’s remaining performance obligation (RPO), a key indicator of future revenue, soared 143% to $4.2 billion, with $1.6 billion added in the fourth quarter alone.
Management provided an ambitious outlook for 2026, projecting revenue growth of roughly 60% to about $7.19 billion. Within that, U.S. commercial revenue is forecast to climb at least 115% to $3.14 billion.
Should investors sell immediately? Or is it worth buying Palantir?
“AIP Bootcamps” Accelerate Sales Cycle
A driver behind the rapid commercial expansion is Palantir’s innovative sales approach. The company has moved away from lengthy enterprise sales cycles in favor of five-day “AIP Bootcamps.” In these intensive sessions, prospective clients build AI use cases directly with their own data. The company reports a conversion rate nearing 75% for this method, compressing sales processes that once took months into a matter of days.
Analyst Sentiment Turns Bullish
This mix of strong growth signals and geopolitical demand has prompted several analyst upgrades. Both Daiwa Securities and UBS shifted their ratings from “Neutral” to “Buy,” each setting a 12-month price target of $180. UBS cited the stock’s significant pullback from recent highs as improving its risk-reward profile. The aggregated consensus among 28 covering analysts stands at “Moderate Buy,” with an average price target of $187.96, though targets show a wide dispersion from $45 to $255.
Valuation remains a point of debate. According to source data, the stock trades at over 100 times expected earnings—a multiple that implicitly requires sustained high growth rates to justify.
Shares were quoted at €138.34 on Friday, marking a substantial weekly gain of 19.11%.
The coming weeks will be critical for Palantir. Investors will watch closely to see if the company executes a smooth transition away from Anthropic in its Maven systems and whether the remarkable momentum in its U.S. commercial business continues. The company’s ambitious 2026 revenue trajectory depends heavily on both.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from March 7 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 7.
Palantir: Buy or sell? Read more here...








